Newsroom
Category
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story in Yahoo addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
July 1, 2021
Dr. Jason Bowling, Infectious Diseases, discusses for KSAT 12 audiences the latest developments with the Delta variant and how the Covid-19 vaccines stand up against it; he refers to the partnership between University Health and UT Health San Antonio. Read story
July 1, 2021
Dr. Ruben Mesa, executive director of the Mays Cancer Center, was quoted in this story about the Mays Cancer Center at UT Health San Antonio joining three other institutions to participate in a new Advancing Inclusive Research Site Alliance launched by San Francisco-based Genentech. Read story
July 1, 2021
Ali Seifi, MD, an associate professor of neurosurgery in UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine, is quoted in this story about HiccAway. Read story
July 1, 2021
Dr. Jason E. Bowling, an infectious disease specialist at UT Health San Antonio, was quoted in this story about the COVID-19 delta variant spreading in San Antonio. Read story
July 1, 2021
Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in a story about a study that shows nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose. Read story